User:GarryGaller2/sandbox

John R. Stuelpnagel is an American venture capitalist, inventor, medical researcher and publicist, specializing in biotechnology. He is mostly known for business and research contributions to DNA sequencing technology through co-founding Illumina, Inc., a company that helped to reduce the cost of sequencing a human genome. Stuelpnagel has also co-founded and ran multiple early-stage growth companies related to biotechnologies or genomics. Stuelpnagel holds 35 issued U.S. patents.

Background
Stuelpnagel finished his graduate studies at the University of California, Davis, where he received his B.S in biochemistry in 1979. Continuing his studies at the University of California, Davis, Stuelpnagel attained his D.V.M. within the field of Veterinary Medicine. In 1995, he entered the UCLA Anderson School of Management, where he earned a Master of Business Administration in 1997. Stuelpnagel's research interests have been in the area of biotechnology and biochemistry with the main focus being on genetic sequencing and its applications in various fields of science. His work has been published in medical and biochemistry related journals. He is also co-inventor on 35 granted and 76 pending patents assigned by the United States Patent and Trademark Office (USPTO).

Entrepreneurial activity
John Stuelpnagel co-founded and served as Chairman or CEO on a number of organization boards, including Illumina, Inc., 10x Genomics, Fabric Genomics, Element Biosciences,